These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25371112)

  • 1. Structure and dynamics of DRD4 bound to an agonist and an antagonist using in silico approaches.
    Jatana N; Thukral L; Latha N
    Proteins; 2015 May; 83(5):867-80. PubMed ID: 25371112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting.
    Jatana N; Thukral L; Latha N
    J Mol Model; 2016 Jan; 22(1):14. PubMed ID: 26680992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870.
    Zhou Y; Cao C; He L; Wang X; Zhang XC
    Elife; 2019 Nov; 8():. PubMed ID: 31750832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of rare variants in human dopamine receptor D4 gene by genotype-phenotype correlations.
    Michealraj KA; Jatana N; Jafurulla ; Narayanan L; Chattopadhyay A; Thelma BK
    Neuroscience; 2014 Mar; 262():176-89. PubMed ID: 24406443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity and activation of dopamine D3R from molecular dynamics.
    Feng Z; Hou T; Li Y
    J Mol Model; 2012 Dec; 18(12):5051-63. PubMed ID: 22752545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the structural impact of S311C mutation in DRD2 receptor by molecular dynamics & docking studies.
    Podder A; Pandey D; Latha N
    Biochimie; 2016 Apr; 123():52-64. PubMed ID: 26805384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling, molecular dynamic simulation, and docking based binding site analysis of human dopamine (D4) receptor.
    Khoddami M; Nadri H; Moradi A; Sakhteman A
    J Mol Model; 2015 Feb; 21(2):36. PubMed ID: 25650117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.
    Ferraro M; Decherchi S; De Simone A; Recanatini M; Cavalli A; Bottegoni G
    Eur J Med Chem; 2020 Feb; 188():111975. PubMed ID: 31940507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
    Boeckler F; Lanig H; Gmeiner P
    J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of allosteric coupling in human β2-adrenergic receptor in the presence of intracellular loop 3.
    Ozgur C; Doruker P; Akten ED
    BMC Struct Biol; 2016 Jul; 16(1):9. PubMed ID: 27368374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
    Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
    Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations.
    Tewatia P; Agrawal N; Gaur M; Sahi S
    Biochimie; 2014 Jun; 101():168-82. PubMed ID: 24508605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
    Pang X; Yang M; Han K
    Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.